BioLargo, Inc. (BLGO)
0.0809
0.00 (0.00%)
USD |
OTCM |
Oct 02, 16:00
BioLargo Net Income (Quarterly) : -4.00M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -4.00M |
| March 31, 2026 | -3.405M |
| December 31, 2025 | -4.142M |
| September 30, 2025 | -7.244M |
| June 30, 2025 | -1.882M |
| March 31, 2025 | -1.921M |
| December 31, 2024 | -1.732M |
| September 30, 2024 | -1.06M |
| June 30, 2024 | -0.78M |
| March 31, 2024 | -0.775M |
| December 31, 2023 | -1.02M |
| September 30, 2023 | -1.508M |
| June 30, 2023 | -1.626M |
| March 31, 2023 | -0.494M |
| December 31, 2022 | -1.408M |
| September 30, 2022 | -0.847M |
| June 30, 2022 | -1.333M |
| March 31, 2022 | -1.544M |
| December 31, 2021 | -1.791M |
| September 30, 2021 | -1.435M |
| June 30, 2021 | -1.79M |
| March 31, 2021 | -1.878M |
| December 31, 2020 | -1.993M |
| September 30, 2020 | -2.39M |
| June 30, 2020 | -2.701M |
| Date | Value |
|---|---|
| March 31, 2020 | -2.616M |
| December 31, 2019 | -2.815M |
| September 30, 2019 | -3.886M |
| June 30, 2019 | -1.987M |
| March 31, 2019 | -2.749M |
| December 31, 2018 | -2.287M |
| September 30, 2018 | -2.380M |
| June 30, 2018 | -3.600M |
| March 31, 2018 | -2.430M |
| December 31, 2017 | -2.401M |
| September 30, 2017 | -2.246M |
| June 30, 2017 | -2.574M |
| March 31, 2017 | -2.326M |
| December 31, 2016 | -2.278M |
| September 30, 2016 | -2.484M |
| June 30, 2016 | -1.668M |
| March 31, 2016 | -1.644M |
| December 31, 2015 | -1.259M |
| September 30, 2015 | -1.823M |
| June 30, 2015 | -1.30M |
| March 31, 2015 | -0.7862M |
| December 31, 2014 | -0.7575M |
| September 30, 2014 | -0.8371M |
| June 30, 2014 | -1.072M |
| March 31, 2014 | -1.073M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Olin Corp. | -13.30M |
| Stepan Co. | 22.91M |
| Ascent Industries Co. | 0.67M |
| Solesence, Inc. | -0.158M |
| The Chemours Co. | -274.00M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 1.248M |
| Total Expenses (Quarterly) | 4.015M |
| EPS Diluted (Quarterly) | -0.0086 |
| Enterprise Value | 29.63M |
| Gross Profit Margin (Quarterly) | 51.52% |
| Profit Margin (Quarterly) | -320.5% |
| Earnings Yield | -57.13% |
| Normalized Earnings Yield | -57.00 |